Can Pencil Beam Proton Therapy Revolutionize Cancer Care?
Executive Summary
In the billion dollar market for radiotherapy products, pencil beam proton therapy could potentially revolutionize cancer care but the technology is very expensive, and it remains to be seen how many medical institutions in the US and worldwide will be interested in adopting the large systems, which require years to construct. Scripps Proton Therapy Center medical director Carl Rossi, MD, speaks about the benefits of proton therapy compared with other types of radiation therapy.
You may also be interested in...
Global Radiation Therapy Systems Market Expected to Reach $5.6B by 2020
Although immunotherapy and other cutting-edge technologies have dominated the spotlight in cancer treatment over the last several years, the use of radiation therapy is rapidly increasing as physicians look to this non-invasive, cost-effective treatment to address a broad and growing number of cancers. Valued at nearly $4.3 billion in 2015, the global radiation therapy market is growing at a CAGR of 5.5%, and is projected to reach $5.6 billion by 2020, according to a recent report from Medtech Insight.
Reducing Radiation Exposure
The use of cancer radiation therapy and interventional fluoroscopy is expanding rapidly, and medtech start-ups are pioneering innovative technologies to capitalize on the industry-wide movement to reduce radiation exposure and improve outcomes. Profiles of ControlRad Systems, Nanovi, and SoniTrack Systems.
Clinical Trial Diversity Planning Requires Prevalence-Based Enrollment Goals, Metrics For Gauging Success
Academic and industry experts caution against relying on historical enrollment numbers when setting new targets for under-represented populations and tout real-time monitoring dashboards, as well as a role for data monitoring committees, in assessing whether targets are being met in ongoing studies.